Matrix M News Today

This week Cameroon became the first African country to receive the Mosquirix malaria vaccine for use as a fully tested preventive in a wide range of healthcare settings.

The Serum Institute of India says it has produced more than 20-million doses ahead of the WHO recommendation

About 600 Kenyan children took part in phase three trials for R21 vaccine conducted in Kilifi

Maureen Owiti says her child rarely gets malaria. Other mothers fear the babies are getting too many injections

Ghana is the only country to have approved the vaccine for children between the ages of 5-36 months.

Poverty, human movement, resistance and climate change are the main reasons malaria remains prevalent in Africa

Malaria vaccine is still effective against spread of malaria according to a recent study published in the Lancet Infectious Diseases Malaria is a leading cause of morbidity and mortality ...

Promising new malaria vaccine shows 77% success rate The results came after a year-long trial of 450 children in Burkina Faso 23 April 2021 - 12:35 By Reuters A potential malaria shot, called R21/Matrix-M, showed up to 77% efficacy in the year-long trial of 450 children in Burkina Faso, according to scientists. Image: REUTERS A potential new malaria vaccine has proved highly effective in a trial in babies in Africa, pointing to it one day possibly helping reduce t...